Immutep Days Sales Outstanding from 2010 to 2025

IMMP Stock  USD 1.82  0.01  0.55%   
Immutep Days Sales Outstanding yearly trend continues to be relatively stable with very little volatility. Days Sales Outstanding is likely to drop to 709.76. During the period from 2010 to 2025, Immutep Days Sales Outstanding destribution of quarterly values had range of 17.9 K from its regression line and mean deviation of  3,370. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
747.11
Current Value
709.76
Quarterly Volatility
5.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Immutep financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immutep's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 26.2 K or Selling General Administrative of 9.3 M, as well as many indicators such as Price To Sales Ratio of 80.26, Dividend Yield of 0.0 or PTB Ratio of 2.06. Immutep financial statements analysis is a perfect complement when working with Immutep Valuation or Volatility modules.
  
Check out the analysis of Immutep Correlation against competitors.

Latest Immutep's Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Immutep Ltd ADR over the last few years. It is Immutep's Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immutep's overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Pretty Stable
   Days Sales Outstanding   
       Timeline  

Immutep Days Sales Outstanding Regression Statistics

Arithmetic Mean2,321
Geometric Mean444.43
Coefficient Of Variation229.48
Mean Deviation3,370
Median483.19
Standard Deviation5,326
Sample Variance28.4M
Range17.9K
R-Value0.22
Mean Square Error28.9M
R-Squared0.05
Significance0.41
Slope247.68
Total Sum of Squares425.5M

Immutep Days Sales Outstanding History

2025 709.76
2024 747.11
2022 830.13
202117.9 K
2020 578.7
2019 165.36
201813.7 K

About Immutep Financial Statements

Immutep shareholders use historical fundamental indicators, such as Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Although Immutep investors may analyze each financial statement separately, they are all interrelated. The changes in Immutep's assets and liabilities, for example, are also reflected in the revenues and expenses on on Immutep's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Days Sales Outstanding 747.11  709.76 

Additional Tools for Immutep Stock Analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.